$520 Million is the total value of Atika Capital Management LLC's 176 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ADBE | Exit | ADOBE SYS INC | $0 | – | -5,000 | -100.0% | -0.37% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -195,000 | -100.0% | -0.39% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -220,000 | -100.0% | -0.49% | – |
| SHPG | Exit | SHIRE PLCcall | $0 | – | -10,000 | -100.0% | -0.51% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.52% | – |
| CGNX | Exit | COGNEX CORP | $0 | – | -32,000 | -100.0% | -0.57% | – |
| CMA | Exit | COMERICA INC | $0 | – | -21,000 | -100.0% | -0.69% | – |
| DSW | Exit | DSW INCcl a | $0 | – | -96,000 | -100.0% | -0.74% | – |
| JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -20,300 | -100.0% | -0.76% | – |
| NTNX | Exit | NUTANIX INCcl a | $0 | – | -48,000 | -100.0% | -0.81% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -25,000 | -100.0% | -0.81% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -40,000 | -100.0% | -0.99% | – |
| AZUL | Exit | AZUL S Asponsr adr pfd | $0 | – | -85,000 | -100.0% | -1.01% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -98,000 | -100.0% | -1.07% | – |
| NOW | Exit | SERVICENOW INC | $0 | – | -20,000 | -100.0% | -1.13% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -21,500 | -100.0% | -1.19% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCcall | $0 | – | -113,000 | -100.0% | -1.26% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -40,000 | -100.0% | -1.69% | – |
| TEAM | Exit | ATLASSIAN CORP PLCcl a | $0 | – | -100,000 | -100.0% | -1.85% | – |
| GS | Exit | GOLDMAN SACHS GROUP INC | $0 | – | -23,500 | -100.0% | -2.03% | – |
| INCY | Exit | INCYTE CORPput | $0 | – | -72,500 | -100.0% | -2.07% | – |
| CTSH | Exit | COGNIZANT TECHNOLOGY SOLUTIOput | $0 | – | -78,500 | -100.0% | -2.16% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MARTIN MARIETTA MATLS INC | 38 | Q3 2023 | 6.1% |
| NETFLIX INC | 35 | Q2 2023 | 5.6% |
| MICROSOFT CORP | 32 | Q3 2023 | 6.7% |
| AMAZON COM INC | 29 | Q3 2023 | 8.6% |
| LIBERTY MEDIA CORP DELAWARE | 29 | Q2 2023 | 5.3% |
| META PLATFORMS INC | 25 | Q3 2023 | 5.8% |
| INTUITIVE SURGICAL INC | 24 | Q3 2023 | 3.3% |
| ARGENX SE | 23 | Q3 2023 | 1.6% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 5.1% |
| EPAM SYS INC | 22 | Q3 2022 | 1.8% |
View Atika Capital Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Atika Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.